ConductScience.org, home

Paper2201190

Induction of labor with mifepristone (RU 486) in intrauterine fetal death.

Cabrol D and 9 others. Am J Obstet Gynecol, 1990. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Papers, record 2201190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2201190

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of labor with mifepristone (RU 486) in intrauterine fetal death.
PubMed
Journal
Am J Obstet Gynecol
PubMed
Year
1990
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Multicenter Study
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
3.52
iCite
Revised in PubMed
2019-06-15
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cabrol DD
2Dubois CC
3Cronje HH
4Gonnet JMJ M
5Guillot MM
6Maria BB
7Moodley JJ
8Oury JFJ F
9Thoulon JMJ M
10Treisser AA

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Fetal DeathMajor topic
Labor, InducedMajor topic
MifepristoneMajor topic
OxytocicsMajor topic
Adult
Double-Blind Method
Drug Tolerance
Female
Humans
Multicenter Studies as Topic
Pregnancy
Time Factors

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02488642Medical Management of Late Intrauterine Death.Results

Source ClinicalTrials.gov

Download CSV of trials

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42350451Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.NPJ Breast Cancer2026https://conductscience.org/library/papers/42350451PubMed
40221656Inducing labor after fetal demise: a systematic review and meta-analysis of the efficacy and safety of mifepristone and misoprostol combination versus misoprostol alone.BMC Pregnancy Childbirth2025https://conductscience.org/library/papers/40221656PubMed
36158399Clinical Utility of Mifepristone: Apprising the Expanding Horizons.Cureus2022https://conductscience.org/library/papers/36158399PubMed
35928056Second-Trimester Medical Abortion with Misoprostol Preceded by Two Sequential Doses of Mifepristone: An Observational Study.J Obstet Gynaecol India2022https://conductscience.org/library/papers/35928056PubMed
34061352Methods for managing miscarriage: a network meta-analysis.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/34061352PubMed
31206170Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev2019https://conductscience.org/library/papers/31206170PubMed
28333794Route of Delivery in Women With Stillbirth: Results From the Stillbirth Collaborative Research Network.Obstet Gynecol2017https://conductscience.org/library/papers/28333794PubMed
28138973Medical treatments for incomplete miscarriage.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28138973PubMed
20091626Medical treatments for incomplete miscarriage (less than 24 weeks).Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20091626PubMed
19588336Mifepristone for induction of labour.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19588336PubMed
16855990Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev2006https://conductscience.org/library/papers/16855990PubMed
12215721Proven and potential clinical applications of mifpristone (RU486).Rev Endocr Metab Disord2002https://conductscience.org/library/papers/12215721PubMed
9250420Clinical pharmacokinetics of mifepristone.Clin Pharmacokinet1997https://conductscience.org/library/papers/9250420PubMed
7682909Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.Drugs1993https://conductscience.org/library/papers/7682909PubMed
1739787Medical abortion.BMJ1992https://conductscience.org/library/papers/1739787PubMed
1281069Mifepristone. Separating fact from fiction.Drugs1992https://conductscience.org/library/papers/1281069PubMed

Download CSV of cited by

Drugs3

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
OXYTOCINCHEMBL395429Results1https://conductscience.org/library/drugs/CHEMBL395429ChEMBL
MISOPROSTOLCHEMBL606Results1https://conductscience.org/library/drugs/CHEMBL606ChEMBL
ISOSORBIDE DINITRATECHEMBL6622Results1https://conductscience.org/library/drugs/CHEMBL6622ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2201190

GET https://conductscience.org/api/papers/v1/2201190/authors